US approves 10 drugmakers for 340B rebate pilot; AbbVie joins

The US government approved 10 drugmakers to take part in a 340B pilot program letting them offer rebates instead of upfront discounts to certain providers. AbbVie is among the participants in the federal rebate model pilot.

Detected & updated continuously · Source: Nebula